Type
. ELISA inhibition technique for the demonstration of sulphones in body fluids. II. A new method to monitor leprosy patient compliance under field conditions. Leprosy review [Internet]. 1981;52(1):11-8. Available from: http://leprev.ilsl.br/pdfs/1981/v52n1/pdf/v52n1a02.pdf
Type
. Does the suppression of the immune response in pre-clinical lepromatous leprosy affect both cell-mediated and humoral responses in Mycobacterium leprae antigens?. Leprosy review [Internet]. 1981;52(1):102-3. Available from: http://leprev.ilsl.br/pdfs/1981/v52n1/pdf/v52n1a15.pdf
Type
. Sulfonamides and sulfones in dermatologic therapy. International journal of dermatology. 1981;20(2):81-8.
Type
. Frans Hemerijckx. JAMA. 1981;245(4):386.
Type
. On the significance of C2, C4, and factor B polymorphisms in disease. Human genetics. 1981;56(3):235-47.
Type
. Muramidase content of cells in human granulomatous reactions. Pathology. 1981;13(1):101-9.
Type
. Towards a vaccine against leprosy. Leprosy in India. 1981;53(1):88-95.
Type
. Pathologic changes in striated muscles in leprosy. Leprosy in India. 1981;53(1):52-6.
Type
. Serological and immunohistological studies on lepromatous leprosy. International archives of allergy and applied immunology. 1981;64(1):19-24.
Type
. Recent European research activities in mycobacteriology. Tubercle. 1980;61(4):259-68.
Pagination
- Previous page
- Page 1228
- Next page